Pathstone Family Office’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$10.3K 1498
2022
Q2
$10.3K Buy
+10,000
New +$476K ﹤0.01% 1040

Other funds holding LRCX

Pathstone Family Office's LRCX Position: Q3 2023 in Review

Pathstone Family Office increased its Lam Research (LRCX) stake by 132% in Q3 2023, buying an estimated $4.28M and bringing the position to 114,460 shares worth $7.33M. The position accounts for 0.06% of the portfolio, ranked #211.

Pathstone Family Office first reported a position in LRCX in Q2 2016 and has held it in 29 quarters since. 1,449 funds tracked by Wall St. Rank hold LRCX as of Q3 2023.

  • Pathstone Family Office held 114,460 shares of Lam Research worth $7.33M as of Q3 2023.
  • Pathstone Family Office bought 65,160 Lam Research shares in Q3 2023, an estimated $4.28M.
  • Lam Research made up 0.06% of Pathstone Family Office's portfolio in Q3 2023, its #211 holding.
  • Pathstone Family Office first reported a position in Lam Research in Q2 2016 and has held it in 29 quarters since.
  • 1,449 funds tracked by Wall St. Rank held Lam Research as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.